StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

Equities research analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of CALA stock opened at $0.00 on Friday. Calithera Biosciences has a 52 week low of $0.00 and a 52 week high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.